An epizootic of simian varicella occurring in a colony of Erythrocebus patas monkeys was studied serologically by using radioimmunoassay and neutralization tests against (i) a virus strain isolated from an animal that died during the epizootic, (ii) a simian varicella virus strain from an earlier outbreak of simian varicella-like disease at another facility, and (iii) human varicella-zoster virus. Serological tests detected more cases of infection among the animals exposed to virus during the epizootic than were evidenced by clinical findings; only 6 of the 26 animals with seroconversion developed a rash. Good correlation was seen between antibody responses demonstrated by radioimmunoassay and by the neutralization tests. Specificity of the radioimmunoassay was evidenced by the complete agreement with neutralization results for 17 animals which failed to show an antibody response over the course of the outbreak and were assumed not to have been infected. Thus radioimmunoassay is a reliable, rapid, and relatively economical method which could be used for serological screening of primates entering experimental colonies to identify those which might be potential sources of outbreaks through activation of latent simian varicella virus infection. Close correlation was seen between antibody responses to the virus strain from the current outbreak and the one from another epizootic, indicating that the two outbreaks were caused by antigenically similar viruses. Animals showing neutralizing antibody responses to the simian varicella viruses also showed responses to human varicella-zoster virus, which further substantiates the close antigenic relationship between human and simian varicella viruses.
An epizootic of simian varicella occurring in a colony of Erythrocebus patas monkeys was studied serologically by using radioimmunoassay and neutralization tests against (i) a virus strain isolated from an animal that died during the epizootic, (ii) a simian varicella virus strain from an earlier outbreak of simian varicella-like disease at another facility, and (iii) human varicella-zoster virus. Serological tests detected more cases of infection among the animals exposed to virus during the epizootic than were evidenced by clinical findings; only 6 of the 26 animals with seroconversion developed a rash. Good correlation was seen between antibody responses demonstrated by radioimmunoassay and by the neutralization tests. Specificity of the radioimmunoassay was evidenced by the complete agreement with neutralization results for 17 animals which failed to show an antibody response over the course of the outbreak and were assumed not to have been infected. Thus radioimmunoassay is a reliable, rapid, and relatively economical method which could be used for serological screening of primates entering experimental colonies to identify those which might be potential sources of outbreaks through activation of latent simian varicella virus infection. Close correlation was seen between antibody responses to the virus strain from the current outbreak and the one from another epizootic, indicating that the two outbreaks were caused by antigenically similar viruses. Animals showing neutralizing antibody responses to the simian varicella viruses also showed responses to human varicella-zoster virus, which further substantiates the close antigenic relationship between human and simian varicella viruses. Antibody assays were performed on paired sera. The first sera were collected from asymptomatic animals 12 days after the occurrence of the index case. The second sera were collected approximately 3 months later when the outbreak had subsided. Thirty-one of the animals received antiviral prophylaxis with phosphonoacetic acid or phosphonoformate for the duration of the epizootic (2) . Single sera were tested on six male and five female animals that died during the outbreak.
Antibody assays. The RIA for immunoglobulin G (IgG) antibodies to simian varicella virus has been described (2). The antigen was prepared from a virus strain (LBI strain) isolated from a lymph node of an animal that died during the epizootic. This strain was kindly provided by William London (National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, Md.). Assays for neutralizing antibodies to the simian varicella viruses were performed as recently described (6), using the BS-C-1 line of grivet monkey kidney cells, cell-free preparations of the LBI virus strain, and the 592S strain of Delta herpes-virus (DHV). Guinea pig complement at a concentration of approximately 50 hemolytic units was used in the serum-virus mixtures to enhance neutralization. Neutralizing antibody to human VZV was 902 SCHMIDT ET AL. assayed as described elsewhere (7), also using complement to enhance neutralization. Table 1 summarizes the serological responses of the 48 patas monkeys which survived the epizootic. Nine of the 11 animals from the male care area where the outbreak originated showed seroconversion to simian and human varicella viruses by all four antibody assays, with the exception of one animal which failed to show an antibody response by RIA. The other two animals from the male care area had low levels of antibody detectable by neutralization, but not by RIA, in their first serum specimens. Both of these animals showed fourfold or greater increases in antibody titer between their first and second serum specimens by all four assay methods. Only 3 of the 11 animals which showed serological evidence of simian varicella virus infection had a rash or other signs of acute infection.
RESULTS
Seroconversion occurred in 17 of 37 animals in the female care area ( Table 1) . Three of these animals had rash. Three female monkeys showed antibody in their first serum specimens and failed to show fourfold or greater increases in antibody levels in all neutralization assays ( Table 2) . Seventeen of the 37 female monkeys had no antibody demonstrable by any assay in either their acute-or convalescent-phase sera, and apparently they were not infected during the epizootic.
Sera from six male and five female animals which died during the epizootic were assayed for neutralizing antibodies to the LBI and DHV viruses and by RIA. The sera were collected 2 to 10 days before the animals showed signs of illness. Titers were <1:4 by neutralization and Table 3 summarizes the antibody levels demonstrated by the three neutralization tests and by RIA. Neutralizing antibody titers against the two strains of simian varicella were not significantly different, but neutralizing antibody titers against human VZV were significantly lower than those against simian varicella virus strains. Titers were markedly higher by RIA than by neutralization. Figure 1 shows the correlation between antibody titers demonstrated by neutralization against the LBI virus strain and those demonstrated in the other two neutralization test systems and by RIA. There was excellent correlation between neutralizing antibody titers against the two simian varicella strains. There was also a positive correlation between neutralizing antibody titers to simian and human varicella virus- es, but titers to the human VZV were lower. There was a wide scattering of RIA titers, but higher RIA titers were associated with higher levels of neutralizing antibody. 
DISCUSSION

